Stay updated with breaking news from Recovery Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A pharmacist shows a box of tocilizumab, which is used to treat rheumatoid arthritis, in the pharmacy of Cambrai Hospital in France on April 28, 2020.
Long COVID patients are more likely to utilize healthcare services after their initial infection, resulting in increased costs.
The clinical trial aims to identify solutions to combat the respiratory symptoms of post-acute COVID syndromeParticipants invited to apply for clinical trialCOCOA BEACH, FL / ACCESSWIRE / October 13, 2021
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
I am a professor of Sociology and by courtesy, of Epidemiology and Public Policy. I am also a Research Professor in the Population Studies Center and Research Affiliate in the Survey Research Center, both at the Institute for Social Research, and am the incoming director of the Population Studies Center. I have a publication record in social and health science journals in the areas of the life course determinants of health and wellbeing in later life and related health disparities, and have received funding for my research and for data collection in these areas from NIH and private foundation...